Chemical Structure and Pharmacodynamic Properties
chemically, bupivacaine is classified as a substituted amino-amide. Structurally, it shares similarities with lidocaine, but it significantly exceeds lidocaine in potency and duration of action. In clinical practice, this drug is traditionally used as the hydrochloride salt.
The drug's pharmacodynamics are characterized primarily by its status as one of the most active local anesthetics available in modern medicine. Its main distinctive feature is the ability to induce exceptionally potent and, crucially, long-lasting anesthesia. The effect following administration can persist from 3 to 10 hours, and in certain clinical scenarios, this period is even longer. This specific property determines the choice of this amino-amide anesthetic for prolonged procedures.
Dosage Regimens and Solution Concentrations
Because the drug has high potency, strictly controlled concentrations are required to achieve adequate anesthesia, varying according to the chosen regional anesthesia technique. Using the correct percentage is critical to balancing block efficacy and patient safety.
Recommended solution concentrations for various types of anesthesia:
- Infiltration anesthesia: lowest concentration used — 0.25%.
- Nerve block (peripheral nerve trunks and plexuses): range from 0.25% to 0.5%.
- Spinal (subarachnoid) anesthesia: similar to peripheral blocks, 0.25%–0.5% solutions are used.
- Epidural anesthesia: requires a higher concentration — 0.75%.
- Retrobulbar block: also utilizes a 0.75% solution.
Special attention should be paid to the use of the drug in obstetrics and gynecology. A strict limitation is established in this field: only solutions with concentrations strictly within 0.25%–0.5% are permitted. The use of higher concentrations (e.g., 0.75%) in obstetric practice is strictly discouraged due to a sharp increase in the risk of toxic complications.
Toxicological Profile and Intoxication Risks
The high pharmacological potency of long-acting amino-amide anesthetics, including bupivacaine, is inextricably linked to an increased risk of systemic toxicity. Complications may occur due to accidental intravascular injection or exceeding recommended concentrations.
The clinical presentation of toxicity involves severe impairment of two major body systems:
- Central nervous system: overdose manifests with marked neurotoxic effects, the primary sign being the risk of seizures.
- Cardiovascular system: the drug exhibits high cardiotoxicity. Intoxication leads to profound depression of cardiac function. In adverse scenarios, this depression can rapidly progress to complete cardiac arrest.
Due to these fatal risks (seizures, bradycardia, decreased myocardial contractility, and cardiac arrest), careful dosage control is mandatory, particularly in vulnerable patient populations such as pregnant individuals.